The presenting signs of acute leukaemia occur as a result of bone marrow failure and organ inÀ ltration. Increased bleeding tendencies are seen on the skin, gums and mucosal lining. Bleeding in the posterior segment of the eye, namely the retina and vitreous, may occur, but do not usually cause any visual disturbances. This case demonstrates visual loss as a result of premacular subhyaloid haemorrhage in acute leukaemia. (JUMMEC 2008; 11(1): 30-32) 
Discussion
Subhyaloid haemorrhage is de½ ned by its location between the vitreous and the retina. Separation of vitreous from the retina by a collection of blood in the macula region, otherwise known as premacular subhyaloid haemorrhage, may cause sudden loss of vision. Aetiologies include proliferative diabetic retinopathy, retinal venous occlusion, rupture of retinal macroaneurysms, valsalva retinopathy and hematological malignancies. Rennie and colleagues reported that resolution of premacular subhyaloid haemorrhage may occur from 3 to 18 months, depending on the aetiology (1) . In this case, submacular haemorrhage most likely occurred following bouts of non-productive cough in this patient with bleeding tendencies secondary to thrombocytopenia. Reddy
CASE STUDY
JUMMEC 2008:11 (1) and Jackson reported a signi½ cant association between intraretinal haemorrhages and thrombocytopenia in patients with acute lymphablastic leukaemia (ALL) (2). In their study, approximately half of the patients with ALL have retinal manifestations, of which intraretinal haemorrhages and white-centred haemorrhages were the most common. In their earlier study, Reddy and colleagues had demonstrated that the presence of intraretinal haemorrhage was a poor prognostic factor for survival in acute leukaemia (3).
Haemorrhages occurring in the macula lead to visual disturbance, and may cause visual loss if the size of bleed is large. Different techniques have been described to treat premacular haemorrhages. Among these are pars plana vitrectomy (4), intravitreal injection of gas and tissue plasminogen activator (5), and laser posterior hyaloidotomy. Puncturing the posterior hyaloid face with Nd:YAG provides a safe, yet non-invasive and effective treatment (6). This method was ½ rst described by Faulborn in 1988 for an eye with diabetic retinopathy (7). Nili-Ahmadabadi and colleagues reported a 100% success rate with this method, with best improvement noted in patients with Valsalva retinopathy (6, 8) .
Complications are uncommon, and include macular hole and retinal detachment (8) . In summary, this case illustrates visual loss as part of the presenting symptoms of acute leukaemia, caused by premacular subhyaloid haemorrhage. Laser posterior hyaloidotomy provides a good and safe alternative mode of treatment.
